一種無線可吞服的醫療設備，體積如同一個較大的維生素丸，有助于胃排空減緩的鑒別，或者叫做胃輕癱綜合征，多年來一直未能作出全面性診斷。胃輕癱綜合征能夠影響許多患者，包括大約50％的糖尿病和帕金森病患者。

SmartPill胃腸道(GI)監測系統是由SmartPill公司(Buffalo, NY, USA)研發的，已經獲得了美國食品藥品管理局(FDA)的許可，給予該公司在美國銷售使用該套系統和SmartPill pH.p膠囊的授權。
 
Ingestible Capsule Evaluates Patients for Gastroparesis
 
A wireless, ingestible medical device, about the size of a large vitamin pill, will aid in the identification of slow gastric emptying, or gastroparesis, which has been underdiagnosed in patients for years. Gastroparesis is a condition that affects a wide range of patients, including up to an estimated 50% of diabetics and those suffering from Parkinson’s disease.

The SmartPill gastrointestinal (GI) monitoring system developed by SmartPill Corp. (Buffalo, NY, USA) has been cleared by the U.S. Food and Drug Administration (FDA), granting the company authorization for the sale and use of the system and the SmartPill pH.p capsule in the United States.